Results 261 to 270 of about 70,002 (313)
Some of the next articles are maybe not open access.

Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti‐MDA5‐positive dermatomyositis

Journal of Internal Medicine, 2023
To explore the role of peripheral lymphocyte count in phenotyping and prognosis prediction in dermatomyositis (DM) patients with anti‐MDA5 antibodies.
Qiwen Jin   +12 more
semanticscholar   +1 more source

Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.

Rheumatology, 2023
OBJECTIVE Among specific autoantibodies in dermatomyositis, the anti-SAE antibody is rare. We aim to describe clinical characteristics, cancer prevalence, and muscle pathology of anti-SAE positive dermatomyositis.
Juliette Demortier   +32 more
semanticscholar   +1 more source

Identification of Three Different Phenotypes in Anti–Melanoma Differentiation–Associated Gene 5 Antibody–Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease

Arthritis & Rheumatology, 2022
There is substantial heterogeneity among the phenotypes of patients with anti–melanoma differentiation–associated gene 5 antibody–positive (anti‐MDA5+) dermatomyositis (DM), hindering disease assessment and management.
Lingxiao Xu   +27 more
semanticscholar   +1 more source

Characteristics of dermatomyositis patients with and without associated malignancy

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021
Dermatomyositis belongs to the rare idiopathic, inflammatory myositis group. A previously postulated link between some cases of dermatomyositis and malignancy has been established in recent years. Criteria suggestive of a malignancy association are still
J. Lauinger, K. Ghoreschi, S. Volc
semanticscholar   +1 more source

Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis–Associated Interstitial Lung Disease

Arthritis & Rheumatology, 2020
To establish predictive models for mortality in patients with polymyositis/dermatomyositis–associated interstitial lung disease (PM/DM‐ILD) using a combination of initial serum biomarker levels.
T. Gono   +17 more
semanticscholar   +1 more source

Dermatomyositis und juvenile Dermatomyositis

Zeitschrift für Rheumatologie, 2022
Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already occur in children but first onset can also be in older adulthood. Myalgia and muscle weakness can occur later in the course of the disease or even be completely absent in some forms.
Frank, Dressler, Britta, Maurer
openaire   +2 more sources

Dermatomyositis

Journal of the American Academy of Dermatology, 1998
Dermatomyositis is a rare inflammatory myopathy with characteristic skin manifestations and muscular weakness. The disease can be categorized as adult idiopathic, juvenile, or amyopathic dermatomyositis as well as that associated with a connective tissue disease or a malignancy.
S O, Kovacs, S C, Kovacs
openaire   +2 more sources

Dermatomyositis

Clinics in Dermatology, 2006
Dermatomyositis is one of the idiopathic inflammatory myopathies. It is characterized clinically by progressive symmetrical proximal muscle weakness and a characteristic rash. There are patients with rash who have little or no muscle disease. Although the process primarily attacks the skin and the muscles, it is a systemic disease with frequent ...
Jeffrey P, Callen, Robert L, Wortmann
openaire   +2 more sources

Home - About - Disclaimer - Privacy